Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-30

Clinical Trial Update: A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety of three intra-articular injections of Ampion in the knee for osteoarthritis; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ampion

Snippet

Sponsor: Ampio Pharmaceuticals. Inc. | Conditions: Osteoarthritis of the Knee | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-09-30